Next Article in Journal
Venous thromboembolism and prophylaxis in cancer patients
Previous Article in Journal
Enrichment of the educational environment with information and communication technologies: State of art at the Faculty of Pharmacy of Kaunas University of Medicine
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Medicina
Volume 44
Issue 2
10.3390/medicina44020021
medicina-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Medicina is published by MDPI from Volume 54 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Lithuanian Medical Association, Lithuanian University of Health Sciences (LUHS), and Vilnius University.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Vasopressin for treatment of hemodynamic disorders

by
Dalia Adukauskienë
1,*,
Edmundas Ðirvinskas
2 and
Egidijus Këvelaitis
3
1
Clinic of Intensive Therapy
2
Laboratory of Intensive Therapy and Investigations of Hemodynamics, Institute for Biomedical Research
3
Department of Physiology, Kaunas University of Medicine, Lithuania
*
Author to whom correspondence should be addressed.
Medicina 2008, 44(2), 167; https://doi.org/10.3390/medicina44020021
Submission received: 4 June 2007 / Accepted: 8 February 2008 / Published: 13 February 2008
Versions Notes

Abstract

Vasopressin is a 9-amino acid peptide synthesized by magnocellular neurons of the hypothalamus and released from posterior pituitary gland. The primary physiological role of vasopressin is the maintenance of fluid homeostasis. In this review, the classification of vasopressin receptors, namely V1 vascular, V2 renal, V3 pituitary, oxytocin receptors, and purinergic receptors, and the effects of vasopressin on vascular smooth muscles, the heart, and the kidneys are discussed. Mortality rates of vasodilatory (or distributive), for example septic shock, are high. The use of vasopressin is an alternative therapy for vasodilatory shock with better outcome. Vasopressin is effective in resuscitation of adults after ventricular fibrillation or pulseless tachycardia, when epinephrine is not effective.
Keywords: vasopressin; vasopressin receptors; vasodilatory shock; septic shock; resuscitation vasopressin; vasopressin receptors; vasodilatory shock; septic shock; resuscitation

Share and Cite

MDPI and ACS Style

Adukauskienë, D.; Ðirvinskas, E.; Këvelaitis, E. Vasopressin for treatment of hemodynamic disorders. Medicina 2008, 44, 167. https://doi.org/10.3390/medicina44020021

AMA Style

Adukauskienë D, Ðirvinskas E, Këvelaitis E. Vasopressin for treatment of hemodynamic disorders. Medicina. 2008; 44(2):167. https://doi.org/10.3390/medicina44020021

Chicago/Turabian Style

Adukauskienë, Dalia, Edmundas Ðirvinskas, and Egidijus Këvelaitis. 2008. "Vasopressin for treatment of hemodynamic disorders" Medicina 44, no. 2: 167. https://doi.org/10.3390/medicina44020021

APA Style

Adukauskienë, D., Ðirvinskas, E., & Këvelaitis, E. (2008). Vasopressin for treatment of hemodynamic disorders. Medicina, 44(2), 167. https://doi.org/10.3390/medicina44020021

Article Metrics

Back to TopTop